Abstract:Background and Aims Plaque instability is a major pathological determinant of ischemic stroke in patients with carotid atherosclerosis, in which inflammation plays a pivotal role. The neutrophil-plus-monocyte to lymphocyte ratio (NMLR) is a novel systemic inflammatory marker, but its association with carotid plaque stability remains unclear. This study aimed to investigate the relationship between NMLR and carotid plaque stability and to evaluate its predictive value.Methods A total of 211 patients with carotid artery stenosis who underwent carotid endarterectomy were retrospectively enrolled. According to postoperative pathological assessment, patients were classified into a vulnerable plaque group (n=113) and a stable plaque group (n=98). Clinical characteristics and preoperative laboratory parameters were collected, and NMLR and neutrophil-to-lymphocyte ratio (NLR) were calculated. Multivariate Logistic regression analysis was performed to identify independent predictors of plaque vulnerability. Receiver operating characteristic (ROC) curves were used to assess the predictive performance of NMLR and NLR.Results Patients with vulnerable plaques had significantly higher NMLR and NLR levels than those with stable plaques (both P<0.001). Multivariate Logistic regression analysis identified previous stroke history (OR=4.59, 95% CI=2.22-9.50), NMLR (OR=7.07, 95% CI=3.71-13.48), and NLR (OR=5.89, 95% CI=3.09-11.25) as independent predictors of plaque vulnerability. ROC curve analysis demonstrated that NMLR yielded an AUC of 0.83 with an optimal cutoff value of 2.71, showing a sensitivity of 86.7% and a specificity of 69.7%. The AUC of NLR was 0.79, with comparable predictive performance.Conclusion NMLR, an inflammatory marker integrating the pro-inflammatory effects of neutrophils and monocytes and the protective role of lymphocytes, is closely associated with carotid plaque instability and exhibits good predictive value. It may serve as a convenient and effective tool for risk stratification and stroke prevention in patients with carotid atherosclerosis.